Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Research and development - MRTP

Sales, general and administrative

Impairment of intangible assets

Depreciation

Amortization

Other operating expense, net

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

22nd Century Group

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

22nd Century Group advances VLN and GVB units towards profitability

22nd Century Group's Q4 2022 earnings call highlighted progress in VLN tobacco and GVB hemp/cannabis units, with plans for multi-state launches and cash positive operations in 2024. Despite challenges like the Grass Valley facility fire, the company remains focused on achieving profitability through revenue growth and market expansion. Key strengths include successful pilot results, volume growth, and a clear path to cash positivity for both business units.

22nd Century Group (XXII) reports strong Q1 performance and growth strategies

22nd Century Group (XXII) showcases strong performance and strategic initiatives to drive revenue growth and achieve cash positivity by 2024.
Despite challenges such as analyst inquiries and insurance impacts, the company's focus on cost efficiencies and margin improvements positions it for success.
Opportunities in revenue growth, bulk ingredient capacity expansion, and margin enhancements present promising prospects for future profitability and market growth.

22nd Century Group reports strong Q2 performance amidst operational challenges

22nd Century Group's Q2 performance showcased growth in sales but faced challenges in gross profit due to production mix shifts.
The company's proactive strategies for cost savings, brand value creation, and gross margin improvement indicate a focus on long-term sustainability.
Despite challenges like VLN rollout delays and tobacco business hurdles, opportunities in market differentiation and efficiency improvements are being pursued.

22nd Century Group pursues profitability through strategic shifts and cost management

22nd Century Group's Q4 2023 earnings call highlighted efforts to achieve profitability by reducing cash burn, focusing on VLN cigarettes for harm reduction, and exploring CMO opportunities in tobacco manufacturing. Despite challenges like decreased net sales and a negative gross profit, the company aims to reach breakeven by Q1 2025.

22nd Century Group reduces cash burn, aims for profitability by 2025

22nd Century Group's Q1 2024 performance reflects progress towards profitability, with improved financial discipline and operational efficiency.
While facing revenue challenges and legal disputes, the company's strategic initiatives and investor support position it for future growth and success.
The focus on reducing losses, strengthening the balance sheet, and expanding market presence underscores the company's commitment to long-term sustainability.

22nd Century Group reports Q2 financial turnaround and growth strategies

22nd Century Group's Q2 2024 performance reflects a notable financial turnaround and progress towards profitability.
Strategic initiatives, leadership appointments, and product strategies position the company for future growth and success.
While challenges remain in achieving cash positive operations, opportunities in market expansion and product innovation offer avenues for continued advancement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

CMO customer adds to previously announced cigarette export business with combined volume significantly adding to profitability Mocksville, North Carolina--(Newsfile Corp. - September 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced a commitment from an existing customer to also supply their filtered cigar products. As part of this customer relationship, 22nd Century Group will assume production of all the customer's filtered cigar products using an in-house predicate blend.

22nd Century Continues CMO Business Expansion with Additional Filtered Cigar Volume

New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile Mocksville, North Carolina--(Newsfile Corp. - September 23, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced a new customer agreement to supply its Moonlight branded cigarettes to the Southeast Asia marketplace. The first shipment is expected in the fourth quarter of 2024, with the opportunity to significantly expand volumes as the customer launches in key markets throughout 2025.

22nd Century Announces New Branded Products Order with Customer for Southeast Asia

Low nicotine tobacco stock on hand can supply up to $85.0 million worth of VLN® revenue and positive cash flow Plans announced for VLN® targeted distribution and expansion to reach over 270,000 retail outlets, expanded international activity, and flanker VLN® brands with existing CMO private label customers Mocksville, North Carolina--(Newsfile Corp. - September 11, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced plans to expand distribution of its VLN® 95% reduced nicotine content smoking products. Based on recent consumer point-of-sale data on VLN® sales, the Company is now moving to expand its sales and marketing operations to all available retail outlets in the US as well as growing its distributions worldwide.

22nd Century Updates Strategic Growth Initiatives for VLN

Mocksville, North Carolina--(Newsfile Corp. - September 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company leading the fight against nicotine addiction with its FDA authorized 95% less nicotine brand VLN®, today announced an agreement to fund all intellectual property, licensing and sponsored research payments to North Carolina State University through 2025 in equity as part of a deal valued at over $1.2 million. The payments will occur over the course of three tranches, in equity or cash, at the company's election.

22nd Century Satisfies IP Licensing and Sponsored Research Obligations to NCSU Through 2025 in an Equity Transaction

Mocksville, North Carolina--(Newsfile Corp. - September 6, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company leading the fight against nicotine with its 95% less nicotine brand VLN® focused on nicotine harm reduction and contract manufacturing, today announced that it will participate in the HC Wainwright Conference on September 10, 2024 at the Lotte New York Palace Hotel. Investors can register and request meetings with management via their HC Wainwright representative.

22nd Century Group to Participate in the HC Wainwright Conference on September 10, 2024

Mocksville, North Carolina--(Newsfile Corp. - August 28, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it has secured an additional $1.68 million in gross proceeds from institutional investors through its Regulation A offering priced at $0.57 and from a separate private placement of common warrants. The Company also entered into an amendment to its existing debentures held by JGB Partners and related entities ("JGB").

22nd Century Raises $1.68 Million in Regulation A Offering, Amends Senior Secured Credit Facility

Mocksville, North Carolina--(Newsfile Corp. - August 20, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it will provide a brief corporate update as part of the Emerging Growth Virtual Conference on Wednesday, August 21, 2024 at 4:25 PM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.

22nd Century Group to Participate in the Emerging Growth Virtual Conference on August 21, 2024

Citizens

Cadrenal Therapeutics Inc

Elutia Inc

Euda Health Holdings Ltd

Cytomed Therapeutics Ltd

Gossamer Bio Inc

Geovax Labs

Immuron

Intelligent Bio Solutions Inc

iQSTEL Inc.

Prospector LeddarTech Almalco

Nature's Miracle California Inc

Pure Cycle

Peraso

SunCar Technology Group Inc

MIAMI, Aug. 20, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 74th Emerging Growth Conference on August 21 – 22, 2024.

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

22nd Century Group, Inc. (NASDAQ:XXII ) Q2 2024 Earnings Conference Call August 13, 2024 8:00 PM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Daniel Otto - CFO Conference Call Participants Matt Kreps Hello and welcome to 22nd Century's Second Quarter Results Conference Call. Joining me today are Larry Firestone, CEO; and Dan Otto, CFO.

22nd Century Group, Inc. (XXII) Q2 2024 Earnings Call Transcript

Path to Cash Positive Operations in Q1 2025; Continued Fiscal Discipline with 2Q24 Financial Results; Reduced Net Debt by ~$6.3 Million Year-to-Date Mocksville, North Carolina--(Newsfile Corp. - August 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) today announced results for the second quarter ended June 30, 2024, and provided an update on recent business highlights. Second Quarter 2024 Financial Results (compared to First Quarter 2024, except as noted) All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company's hemp/cannabis franchise in late 2023.

22nd Century Group Reports Second Quarter 2024 Financial Results

Mocksville, North Carolina--(Newsfile Corp. - August 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, will host a webcast on Tuesday, August 13, 2024, at 8:00 AM ET to discuss its 2024 second quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.

22nd Century Group to Announce Second Quarter 2024 Results on August 13, 2024

Almost 30 years of experience in regulated consumer products sales Mocksville, North Carolina--(Newsfile Corp. - July 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced the appointment of Robert Manfredonia as Executive Vice President of Sales and Marketing, effective August 1, 2024. "I am excited to have Robert join 22nd Century as we round out the executive team.

22nd Century Appoints Robert Manfredonia as Executive Vice President of Sales and Marketing

Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced an agreement with Greenbutts, LLC to provide manufacturing space at its Mocksville, North Carolina NASCO manufacturing facility and NASCO staff to operate the manufacturing equipment for an innovative new cigarette filter solution. Greenbutts offers a patented technology to replace single-use, plastic-based filters currently used in tobacco products with water soluble, fully biodegradable filter solutions.

22nd Century Announces New Greenbutts Manufacturing Agreement for Innovative Plant-Based, Biodegradable Cigarette Filters

Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine content cigarettes in South Korea. The new agreement with 22nd Century's local partner, Nico-Tech Korea, Inc., follows an initial test launch conducted in 2022 that identified product updates needed to align with local South Korean cigarette characteristics and appeal to the specific preferences of adult smokers in Korea.

22nd Century to Re-Launch and Expand VLN(R) Presence in South Korea

Mocksville, North Carolina--(Newsfile Corp. - July 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced that it will present at the Emerging Growth Virtual Conference on Wednesday, July 17, 2024 at 11:25 AM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.

22nd Century Group to Participate in the Emerging Growth Virtual Conference on July 17, 2024

Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissory note. The amount was paid by GVB directly to the lender under terms of the note executed in conjunction with GVB's December 2023 purchase of 22nd Century Group's previous hemp/cannabis assets.

22nd Century Reduces Debt by Additional $1.5 Million via Payment from GVB

Helped Establish National Scale Distribution and Launch VLN in More Than 5,000 Stores Across the Country Mocksville, North Carolina--(Newsfile Corp. - May 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that John Miller has resigned as President of Tobacco, effective August 2, 2024. Said Larry Firestone, Chairman and CEO: "I want to thank John for the pivotal role he played in the launch of VLN®, leveraging his decades of industry experience to help us achieve national-scale distribution and establishing a retail presence in more than 5,000 stores across 26 states.

22nd Century Announces Resignation of John Miller as President of Tobacco

22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2024 Earnings Conference Call May 15, 2024 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Daniel Otto - CFO Conference Call Participants Operator Welcome to the 22nd Century Group's First Quarter 2024 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode.

22nd Century Group, Inc. (XXII) Q1 2024 Earnings Call Transcript

New Contracts to Boost Second Quarter Revenue Reduced Operating Costs, Improved Cash Position Reduced ~$8.0 Million of Outstanding Debt and Liabilities for Equity Exchanges in Q2 2024 Mocksville, North Carolina--(Newsfile Corp. - May 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the first quarter ended March 31, 2024, and provided an update on recent business highlights. First Quarter 2024 Financial Results All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of its hemp/cannabis franchise in late 2023.

22nd Century Group Reports First Quarter 2024 Financial Results

Continues to Improve Balance Sheet and Move Toward Cash Positive Operations Mocksville, North Carolina--(Newsfile Corp. - May 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement to eliminate an additional $2.3 million in outstanding debt with JGB Capital. Under the terms of the agreement, the Company and JGB Capital will exchange an aggregate of $2.3M in principal, fees and expenses owed to JGB Capital for consideration of approximately 1.375 million shares of the Company's common stock and pre-funded warrants.

22nd Century Eliminates an Additional $2.3 Million of Debt

Mocksville, North Carolina--(Newsfile Corp. - May 8, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Aegis Capital Virtual Conference on Thursday, May 9, 2024 at 2:30 PM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.

22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024

Mocksville, North Carolina--(Newsfile Corp. - May 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve health and wellness, will host a live webcast on Wednesday, May 15, 2024, at 8:00 AM ET to discuss its 2024 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.

22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024

Improves Balance Sheet, Eliminates Future Omnia Interest Expense and Increases Shareholder Equity Mocksville, North Carolina--(Newsfile Corp. - April 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement to redeem $5.2 million in outstanding principal and interest associated with the Omnia subordinated note and outstanding warrants. The agreement will exchange consideration of approximately $248,000 in cash, 1.15 million shares of common stock priced at $2.14 per share, and 1.15 million shares of pre-funded warrants priced at $2.14 per share as consideration of the debt.

22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction

Intends to Reduce Board to Four Seats in Upcoming Proxy Mocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that Nora Sullivan and James Mish have resigned as a Directors, effective immediately. The Company does not intend to fill the vacated seats and will instead reduce the board to 4 seats as part of its focus on corporate cost efficiency.

22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors

Continues Focus on Growing Sales with New Contracts, Progress Toward Cash Positive Operations Mocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing. Said Larry Firestone, Chairman and CEO: "We are pleased to regain compliance with the Nasdaq listing standards related to minimum bid price, another win in our efforts to improve our business step by step, every day, with steady progress on all fronts.

News for 22nd Century Group Stock (XXII)